Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Active and recent NIH-funded research on 7q11.23 Microduplication Syndrome. Data from NIH RePORTER, last 36 months.
7q11.23 Microduplication Syndrome has emerging NIH research funding with 1 grant totaling $3.2M.
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for 7q11.23 Microduplication Syndrome. Strongest funded area: Basic Science.
2 clinical trials registered but no NIH-funded clinical or translational research grants found for 7q11.23 microduplication syndrome. Trials may be industry-sponsored or funded through non-NIH sources.